Veteran and Military Mental Health Issues.
Moore MJ, Shawler E, Jordan CH, Jackson CA.
2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Harm potential of magic mushroom use: a review.
van Amsterdam J, Opperhuizen A, van den Brink W.
Regul Toxicol Pharmacol. 2011 Apr;59(3):423-9. doi: 10.1016/j.yrtph.2011.01.006. Epub 2011 Jan 21.
[Flashback following use of cannabis--a review].
Fischer J, Täschner KL.
Fortschr Neurol Psychiatr. 1991 Nov;59(11):437-46. doi: 10.1055/s-2007-1000718.
Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach.
Lerner AG, Gelkopf M, Skladman I, Oyffe I, Finkel B, Sigal M, Weizman A.
Isr J Psychiatry Relat Sci. 2002;39(2):92-9.
[Hallucinogen Persisting Perception Disorder (HPPD) and Flashback Phenomena - Differential Diagnosis and Explanation Models].
Hermle L, Ruchsow M, Täschner KL.
Fortschr Neurol Psychiatr. 2015 Sep;83(9):506-15. doi: 10.1055/s-0035-1553717. Epub 2015 Sep 30.
Flashback: psychiatric experimentation with LSD in historical perspective.
Dyck E.
Can J Psychiatry. 2005 Jun;50(7):381-8. doi: 10.1177/070674370505000703.
[Hallucinogen-induced psychological disorders].
Hermle L, Kovar KA, Hewer W, Ruchsow M.
Fortschr Neurol Psychiatr. 2008 Jun;76(6):334-42. doi: 10.1055/s-2008-1038191.
5-methoxy-N,N-diisopropyltryptamine-induced flashbacks.
Ikeda A, Sekiguchi K, Fujita K, Yamadera H, Koga Y.
Am J Psychiatry. 2005 Apr;162(4):815. doi: 10.1176/appi.ajp.162.4.815.
Hallucinogens: an update.
Halpern JH.
Curr Psychiatry Rep. 2003 Oct;5(5):347-54. doi: 10.1007/s11920-003-0067-4.
LSD flashbacks.
Hoffman JA.
Arch Gen Psychiatry. 1984 Jun;41(6):631-2. doi: 10.1001/archpsyc.1984.01790170105015.
